A novel sleep aid device to reduce sleep latency using air–CO2 mixed gas

Introduction Sleep is an indispensable component of human life. However, in modern times, the number of people suffering from sleep disorders, such as insomnia and sleep deprivation, has increased significantly. Therefore, to alleviate the discomfort to the patient due to lack of sleep, sleeping pills and various sleep aids are being introduced and used. However, sleeping drugs are prescribed only to a limited extent due to the side effects posed by them and resistance to such drugs developed by patients in the long term, and the majority of sleep aids are scientifically groundless products. This study aimed to develop a device that induced sleep by spraying a mixed gas of carbon dioxide and air to create an environment that could induce sleep, similar to the inside of a sealed vehicle, to control oxygen saturation in the body. Methods Based on the stipulated safety standards and the human tidal volume, the target concentration of carbon dioxide was determined to be of three types: 15,000, 20,000, and 25,000 ppm. After analyzing diverse structures for safely mixing gases, the most appropriate shape, the reserve tank, was selected as the best suited structure. Various variables, such as spraying angle and distance, flow rate, atmospheric temperature, and nozzle length, were comprehensively measured and tested. Furthermore based on this aspect, diffusion simulation of carbon dioxide concentration and actual experiments were conducted. To secure the stability and reliability of the developed product, an accredited test was performed to investigate the error rate of carbon dioxide concentration. Furthermore, clinical trials comprising polysomnography and questionnaires confirmed the effectiveness of the developed product not only in reducing sleep latency but also in enhancing the overall sleep quality. Results When the developed device was put to use in reality, sleep latency was decreased by 29.01%, on average, for those with a sleep latency of 5 min or more, compared to when the device was not in use. Moreover, the total sleep time was increased by 29.19 min, WASO was decreased by 13.17%, and sleep efficiency was increased by 5.48%. We also affirmed that the ODI and 90% ODI did not decrease when the device was used. Although different questions may be raised about the safety of using a gas such as carbon dioxide (CO2), the result that tODI was not reduced shows that sleep aids using CO2 mixtures do not adversely affect human health. Discussion The results of this study suggest a new method that can be used to treat sleep disorders including insomnia.

[1]  Su Jung Choi,et al.  Effects of Low-Concentration Carbon Dioxide Exposure at Bedtime on Sleep in Adults With Insomnia Symptoms , 2022, Journal of Sleep Medicine.

[2]  Kathryn P Linthicum,et al.  Sleep disturbances as risk factors for suicidal thoughts and behaviours: a meta-analysis of longitudinal studies , 2020, Scientific Reports.

[3]  C. Victor,et al.  A matched cohort study , 2020 .

[4]  Vijay Kumar Chattu,et al.  The Interlinked Rising Epidemic of Insufficient Sleep and Diabetes Mellitus , 2019, Healthcare.

[5]  F. Cappuccio,et al.  Sleep and Cardio-Metabolic Disease , 2017, Current Cardiology Reports.

[6]  D. Kripke Mortality Risk of Hypnotics: Strengths and Limits of Evidence , 2016, Drug Safety.

[7]  E. Park,et al.  Association between total sleep duration and suicidal ideation among the Korean general adult population. , 2013, Sleep.

[8]  M. Pinquart,et al.  Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. , 2012, The Journal of clinical psychiatry.

[9]  D. Kripke,et al.  Hypnotics' association with mortality or cancer: a matched cohort study , 2012, BMJ Open.

[10]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[11]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, BMC medicine.

[12]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[13]  C. Morin,et al.  Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. , 2009, Sleep medicine.

[14]  Seung Bong Hong,et al.  Epidemiology of Insomnia in Korean Adults: Prevalence and Associated Factors , 2009, Journal of clinical neurology.

[15]  K Jack Ishak,et al.  Meta-analysis of longitudinal studies , 2007, Clinical trials.

[16]  C. Morin,et al.  Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. , 2006, Sleep medicine.

[17]  P. Sharps,et al.  What We Know and What We Still Need to Learn , 2005, Journal of interpersonal violence.

[18]  Seung-Chul Hong,et al.  Prevalence of insomnia and associated factors in South Korea. , 2002, Journal of psychosomatic research.

[19]  Maurice M Ohayon,et al.  Epidemiology of insomnia: what we know and what we still need to learn. , 2002, Sleep medicine reviews.

[20]  M Partinen,et al.  Insufficient sleep--a population-based study in adults. , 2001, Sleep.

[21]  M. Chóliz A Breathing-Retraining Procedure in Treatment of Sleep-Onset Insomnia: Theoretical Basis and Experimental Findings , 1995, Perceptual and motor skills.

[22]  S. Choi,et al.  A study on the sleep patterns of the general adult population in Seoul , 1992 .

[23]  D. Ford,et al.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.

[24]  D. Megirian,et al.  The effects of hypoxia and CO2 on the sleep-waking pattern of the potoroo (Potorous tridactylus apicalis) , 1983, Physiology & Behavior.